This is a phase 1 clinical trial part of the European H2020 ICOD project (Improving COgnition in Down syndrome) coordinated by Prof. Raphael de la Torre Fornell.
International collaboration led by researchers at the Sant Pau Reseach Institute – IIB Sant Pau in Barcelona, Spain, shows effectiveness of a plasma biomarker to detect Alzheimer’s Disease in D...
Research led by King’s College London in collaboration with the Centre for Genomic Regulation (CRG) and the Trisomy 21 Research Society (T21RS) finds increased COVID-19 mortality among adults wit...
Connecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...
European scientists have launched a research programme, which aims to identify common causes of dementia in Alzheimer’s Disease, Parkinson’s Disease and Down Syndrome.
The project brings together...